BioSpace News Archive

Cortexyme, Inc. today provided a business update and announced key milestones for 2022.

Biofidelity, a pioneer in precision cancer diagnostics, has successfully completed a heavily oversubscribed $23 million Series A+ investment round, led by Octopus Ventures and backed by SBI Investment Co. Ltd. and existing investors.

iECURE today announced that it has expanded its management team by adding two experienced industry executives into key roles within the organization.

Acer Therapeutics Inc. announced that Acer’s management team will virtually participate in the BIO CEO & Investor Conference on February 14-17, 2022.

Skye Bioscience, Inc. announced that in a preclinical study assessing the neuroprotective properties of its SBI-100 ophthalmic nanoemulsion, the treated group demonstrated a trend of retaining greater function of the eye’s retinal ganglion cells.

Quotient Limited, a commercial-stage diagnostics company headquartered in Eysins, Switzerland, announced its attendance for the first time to the Arab Health and Medlab Middle East Conference in Dubai, United Arab Emirates.

Catalent, Inc. today announced financial results for the second quarter of fiscal 2022, which ended December 31, 2021.

Mydecine Innovations Group today announced in preparation for its FDA pre-Investigational New Drug (IND) meeting on February 28th, the company has submitted a pre-IND briefing package to the U.S. Food and Drug Administration (FDA) for a clinical study evaluating MYCO-001 in a structured smoking cessation treatment program.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from Cohort 3 of REDWOOD-HCM.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022, after the market closes.